S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for advanced gastric carcinoma: a meta-analysis.
<h4>Background</h4>Although both oral fluoropyrimidines were reported effective and safe, doubts exist about whether S-1 or capecitabine is more advantageous in advanced gastric carcinoma (AGC). Herein, we performed a meta-analysis to comprehensively compare the efficacy and safety of S-...
Saved in:
Main Authors: | Ming-ming He, Wen-jing Wu, Feng Wang, Zhi-qiang Wang, Dong-sheng Zhang, Hui-yan Luo, Miao-zhen Qiu, Feng-Hua Wang, Chao Ren, Zhao-Lei Zeng, Rui-hua Xu |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/e4a9caaabaf54f44a3da5b9a0be41b7d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A polymorphism in ABCC4 is related to efficacy of 5-FU/capecitabine-based chemotherapy in colorectal cancer patients
by: Qi Chen, et al.
Published: (2017) -
Severe ileum bleeding following adjuvant capecitabine chemotherapy for locally advanced colon cancer: a case report and review of the literature
by: You Zou, et al.
Published: (2021) -
Efficacy and safety of taxane-based systemic chemotherapy of advanced gastric cancer: A systematic review and meta-analysis
by: Jinxin Shi, et al.
Published: (2017) -
First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
by: Christian Möhring, et al.
Published: (2021) -
The Clinical Value of Chemotherapy Combined With Capecitabine in Triple-Negative Breast Cancer—A Meta-Analysis
by: Zilin Zhang, et al.
Published: (2021)